SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study

समान संसाधन

• Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
  द्वारा: Cadegiani, Flavio A., और अन्य
  प्रकाशित: (2020)
• Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism
  द्वारा: Yale, Katerina, और अन्य
  प्रकाशित: (2021)
• Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
  द्वारा: Cadegiani, Flavio A., और अन्य
  प्रकाशित: (2020)
• SARS‐CoV‐2 infection in patients with atopic dermatitis: a cross‐sectional study
  द्वारा: Nguyen, C., और अन्य
  प्रकाशित: (2021)
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
  द्वारा: Wambier, Carlos Gustavo, और अन्य
  प्रकाशित: (2020)